摘要
2019年底我国武汉地区爆发新型冠状病毒肺炎(以下简称“新冠肺炎”),从经方医学的角度对当下新冠肺炎疫情进行思考。认为中医学对新冠肺炎模糊的认识不影响按照“有是证用是方”的原则对其进行精确地治疗。经方已经有几千年的应用历史,在长期的临床实践中,古代医家对类似新冠肺炎的时令发热性疾病积累了丰富的临床经验,故按照方证相应的原则提出本次疫情的经方对策,可以小柴胡汤为基本方变化运用,同时强调患者的个体化治疗。在临床治疗过程中不仅要有个体性选方,也要有群体性用药,寻找相应的群体性配方,是当前一项十分紧迫的研究任务,并建议采用荆防败毒散和十神汤,作为疫区群体性预防用方。在具体的治法上应补当补,应攻当攻。
COVID-19 outbroke in Chinese Wuhan municipality at the end of 2019.The author has pondered over it from the perspective of Medicine of Jingfang.It was hold that although traditional Chinese medicine(TCM)just had vague definition of COVID-19,it could not affect the application of precise treatment according to TCM principle of"The prescription is in the light of the symptom".Jingfang has extended over thousands of years and ancient doctors accumulated profound clinical experience of treating seasonal febrile diseases in the long term clinical practice.Therefore,it is feasible to put forward classical prescriptions to treat COVID-19 based on the principle of prescriptions corresponding to syndromes,Modified Xiaochaihu decoction can be applied in accordance with individualized treatment.In clinics,it is essential to prescribe not only for an individual,but also for the population.It is a quite urgent research task to find out appropriate mass formula.Hence,Jingfang Baidu powder and Shishen decoction were proposed as the preventive formula for the population combined with therapeutic methods varying in each individual,like reinforcing method or dispelling therapy.
作者
黄煌
HUANG Huang(International Jingfang Institute, Nanjing University of Chinese Medicine, Nanjing, 210023, China)
出处
《南京中医药大学学报》
CAS
CSCD
北大核心
2020年第2期152-156,共5页
Journal of Nanjing University of Traditional Chinese Medicine
关键词
新冠肺炎
经方
方证相应
小柴胡汤
COVID-19
Jingfang
prescriptions corresponding to syndromes
Xiaochaihu decoction
作者简介
第一作者:黄煌,男,教授,博士生导师,主要从事经方的方证与药证研究,E-mail:hhuang54@163.com。
